Get started
Athira Pharma, Inc.Athira Pharma, Inc.Athira Pharma, Inc.

Athira Pharma, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

ATHA trade ideas

Athira - Hold accumulateAthira Pharma's explosive growth potential is attributed to its innovative therapies aimed at neurological disorders, such as Alzheimer’s, Parkinson’s disease dementia, and dementia with Lewy bodies. The flagship molecule, ATH-107 (also known as fosgonimeton or fosgo), currently in advanced clinical testing, targets the HGF/MET system to promote neuronal health and recovery. Phase 2 trials have yielded encouraging outcomes, with Phase 2/3 results anticipated in the latter half of 2024. Thomas Shrader, a sector expert, underscores fosgo’s potential in treating mild-to-moderate Alzheimer’s, positioning it as a pivotal monotherapy for patients at later stages of the disease. I am looking forward to a price pullback to the $2.50-$2.80 range, considering it an attractive entry point within the liquidity shelf, given the timeline for upcoming trial data. Shrader rates ATHA shares a Buy, and his $10 price target points toward an upside of 200% by the end of this year.
NASDAQ:ATHALong
by SPYDERMARKET
1
ATHA long - $3 downside, huge upsideIm a beginner so this should be pretty easy to understand. This is simply a decent company having some internal issues, but those issues have seemingly been taken care of. The stock now seems to be starting its move back upward. Resistance has been broken, as well as what looks like a strong upwards trend is beginning. A few upcoming catalysts in the next few months should help push this stock higher. I believe we will be at the $20 level before that. Over the last 4 months, this stock hit a low of $8.88, but I dont expect anything under $10 to be touched anytime soon, so I would set a stop around $9, and buy shares based on whatever you can afford to lose. With a $3 downside from $12, I personally wouldnt mind risking $3000, so I would probably buy 1000 shares at $12. I would potentially scale in....in lots of 250. When would I exit this trade? Once the stock hits $20, Id make sure my stop is somewhere around $17.5....and we can consider this a W for us. Unless it gaps way down during non-market hours on bad news....but thats just part of the game?
NASDAQ:ATHALong
by scimonoce
ATHA , Offering play , Long Offering was for 4 million shares at 22.50 per share , expected to close on Jan 25th . I took a position in the aftermarket today after finding this . I like it for the following reasons: -We are trading under book , P/B is 0.59 -Institution ownership is 67.30% I think this will help to reduce further sell off at these prices . -Trading closed below the offering price and I see potential for an 11% gain assuming target price is set just under offering price of $22.50. I think $22.49 is a very modest target given the circumstances . One concern I have: We have not seen a proper reversal or consolidation to help us determine a good entry. Nonetheless, I am willing to enter this far below the offering price . I still like the risk vs reward and I am trying to take advantage of a small price move only. Good luck ~
NASDAQ:ATHALong
by NAK1987
2